| For: | Rodríguez-Bores L, Fonseca GC, Villeda MA, Yamamoto-Furusho JK. Novel genetic markers in inflammatory bowel disease. World J Gastroenterol 2007; 13(42): 5560-5570 [PMID: 17948929 DOI: 10.3748/wjg.v13.i42.5560] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i42/5560.htm |
| Number | Citing Articles |
| 1 |
J. K. Yamamoto‐Furusho, L. Rodríguez‐Bores, J. Granados. HLA‐DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitis. Colorectal Disease 2010; 12(12) doi: 10.1111/j.1463-1318.2009.02025.x
|
| 2 |
K. Krati, H. Ouarrach, F. Pratic, S. Oubaha, Z. Samlani. Les manifestations extradigestives au cours de la maladie de Crohn. Journal Africain d'Hépato-Gastroentérologie 2017; 11(1) doi: 10.1007/s12157-016-0698-9
|
| 3 |
Chuan-Xing Xiao, Jing-Jing Xiao, Hong-Zhi Xu, Huan-Huan Wang, Xu Chen, Yuan-Sheng Liu, Ping Li, Ying Shi, Yong-Zhan Nie, Shao Li, Kai-Chun Wu, Zhan-Ju Liu, Jian-Lin Ren, Bayasi Guleng. Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn’s disease patients. Scientific Reports 2015; 5(1) doi: 10.1038/srep10514
|
| 4 |
C. Reiff, M. Delday, G. Rucklidge, M. Reid, G. Duncan, S. Wohlgemuth, G. Hörmannsperger, G. Loh, M. Blaut, E. Collie-Duguid, D. Haller, D. Kelly. Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 2009; 15(11) doi: 10.1002/ibd.20999
|
| 5 |
Mauro Pinho. A Biologia molecular das doenças inflamatórias intestinais. Revista Brasileira de Coloproctologia 2008; 28(1) doi: 10.1590/S0101-98802008000100018
|
| 6 |
Fernando Casals-Seoane, María Chaparro, José Maté, Javier P. Gisbert. Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2016; 22(8) doi: 10.1097/MIB.0000000000000815
|
| 7 |
George P. Christophi, Rong Rong, Philip G. Holtzapple, Paul T. Massa, Steve K. Landas. Immune markers and differential signaling networks in ulcerative colitis and Crohnʼs disease. Inflammatory Bowel Diseases 2012; 18(12) doi: 10.1002/ibd.22957
|
| 8 |
Markus F. Neurath, Stefan Fichtner-Feigl, Rebecca Kesselring. Mucosal Immunology. 2015; doi: 10.1016/B978-0-12-415847-4.00091-4
|
| 9 |
Jesús K. Yamamoto-Furusho. Genetic Susceptibility in Inflammatory Bowel Disease. Clinical Reviews in Bone and Mineral Metabolism 2010; 8(3) doi: 10.1007/s12018-009-9068-0
|
| 10 |
|
| 11 |
E. Garza‐González, G. I. Pérez‐Pérez, S. I. Mendoza‐Ibarra, J. P. Flores‐Gutiérrez, F. J. Bosques‐Padilla. Genetic risk factors for inflammatory bowel disease in a North‐eastern Mexican population. International Journal of Immunogenetics 2010; 37(5) doi: 10.1111/j.1744-313X.2010.00932.x
|
| 12 |
Maria Luisa Bianchi. Inflammatory bowel diseases, celiac disease, and bone. Archives of Biochemistry and Biophysics 2010; 503(1) doi: 10.1016/j.abb.2010.06.026
|
| 13 |
|
| 14 |
Satoru Suzuki, Takako Takai-Igarashi, Yutaka Fukuoka, Dennis P Wall, Hiroshi Tanaka, Peter J Tonellato. Systems analysis of inflammatory bowel disease based on comprehensive gene information. BMC Medical Genetics 2012; 13(1) doi: 10.1186/1471-2350-13-25
|
| 15 |
D. Praslickova, S. Sharif, A. Sarson, M.F. Abdul-Careem, D. Zadworny, A. Kulenkamp, G. Ansah, U. Kuhnlein. Association of a Marker in the Vitamin D Receptor Gene with Marek's Disease Resistance in Poultry. Poultry Science 2008; 87(6) doi: 10.3382/ps.2008-00006
|
| 16 |
Caroline Reiff, Denise Kelly. Inflammatory bowel disease, gut bacteria and probiotic therapy. International Journal of Medical Microbiology 2010; 300(1) doi: 10.1016/j.ijmm.2009.08.004
|
| 17 |
D. Lough, J. Abdo, J.F. Guerra-Castro, C. Matsumoto, S. Kaufman, K. Shetty, Y.K. Kwon, M. Zasloff, T.M. Fishbein. Abnormal CX3CR1+ Lamina Propria Myeloid Cells From Intestinal Transplant Recipients with NOD2 Mutations. American Journal of Transplantation 2012; 12(4) doi: 10.1111/j.1600-6143.2011.03897.x
|
| 18 |
Iain Comerford, Mark Bunting, Kevin Fenix, Sarah Haylock‐Jacobs, Wendel Litchfield, Yuka Harata‐Lee, Michelle Turvey, Julie Brazzatti, Carly Gregor, Phillip Nguyen, Ervin Kara, Shaun R. McColl. An immune paradox: How can the same chemokine axis regulate both immune tolerance and activation?. BioEssays 2010; 32(12) doi: 10.1002/bies.201000063
|
| 19 |
Feng Hua PEI, Yan Jun WANG, Shan Ling GAO, Bing Rong LIU, Ya Ju DU, Wei LIU, Hong Ying YU, Li Xia ZHAO, Bao Rong CHI. Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese. Journal of Digestive Diseases 2011; 12(2) doi: 10.1111/j.1751-2980.2011.00483.x
|
| 20 |
Mohammad Salem, Jakob Benedict Seidelin, Gerhard Rogler, Ole Haagen Nielsen. Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyond. Cellular and Molecular Life Sciences 2013; 70(18) doi: 10.1007/s00018-012-1246-4
|
| 21 |
Marek Vebr, Renáta Pomahačová, Josef Sýkora, Jan Schwarz. A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. Biomedicines 2023; 11(12) doi: 10.3390/biomedicines11123229
|
| 22 |
|
| 23 |
|
| 24 |
Kristine Holgersen, Ross Dobie, Colin Farquharson, Rob vanʼt Hof, Syed Faisal Ahmed, Axel Kornerup Hansen, Thomas L. Holm. Piroxicam Treatment Augments Bone Abnormalities in Interleukin-10 Knockout Mice. Inflammatory Bowel Diseases 2015; 21(2) doi: 10.1097/MIB.0000000000000269
|
| 25 |
Manyi Sun, Li Zhang, Songli Shi. Associations between NRAMP1 Polymorphisms and Susceptibility to Ulcerative Colitis/Crohn’s Disease: A Meta-Analysis. Immunological Investigations 2016; 45(3) doi: 10.3109/08820139.2016.1149191
|
| 26 |
Paul D. Terry, Francois Villinger, George A. Bubenik, Shanti V. Sitaraman. Melatonin and ulcerative colitis: Evidence, biological mechanisms, and future research. Inflammatory Bowel Diseases 2009; 15(1) doi: 10.1002/ibd.20527
|
| 27 |
Le-Ning Xue, Ke-Qun Xu, Wei Zhang, Qiang Wang, Jia Wu, Xiao-Yong Wang. Associations Between Vitamin D Receptor Polymorphisms and Susceptibility to Ulcerative Colitis and Crohnʼs Disease. Inflammatory Bowel Diseases 2013; 19(1) doi: 10.1002/ibd.22966
|
| 28 |
Rajkumar Cheluvappa. Experimental appendicitis and appendectomy modulate the CCL20–CCR6 axis to limit inflammatory colitis pathology. International Journal of Colorectal Disease 2014; 29(10) doi: 10.1007/s00384-014-1936-5
|
| 29 |
Harumi Jyonouchi, Lee Geng, Agnes Cushing-Ruby, Iona M. Monteiro. Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen. Pediatric Allergy and Immunology 2009; 21(4p2) doi: 10.1111/j.1399-3038.2009.00923.x
|
| 30 |
|
| 31 |
Anastassios C. Manolakis, Andreas N. Kapsoritakis, Anastasia Kapsoritaki, Elisavet K. Tiaka, Konstantinos A. Oikonomou, Vassilis Lotis, Dimitra Vamvakopoulou, Ioanna Davidi, Nikolaos Vamvakopoulos, Spyros P. Potamianos. Readressing the Role of Toll-Like Receptor-4 Alleles in Inflammatory Bowel Disease: Colitis, Smoking, and Seroreactivity. Digestive Diseases and Sciences 2012; doi: 10.1007/s10620-012-2348-4
|
| 32 |
Xiaona Yang, Hong Guo, Min Zou. Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives. Molecular Biomedicine 2026; 7(1) doi: 10.1186/s43556-025-00395-z
|
| 33 |
Rosalba Salcedo, Andrea Worschech, Marco Cardone, Yava Jones, Zsofia Gyulai, Ren-Ming Dai, Ena Wang, Winnie Ma, Diana Haines, Colm O'hUigin, Francesco M. Marincola, Giorgio Trinchieri. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. Journal of Experimental Medicine 2010; 207(8) doi: 10.1084/jem.20100199
|
| 34 |
Maya Saleh, Giorgio Trinchieri. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nature Reviews Immunology 2011; 11(1) doi: 10.1038/nri2891
|
| 35 |
|
| 36 |
Bo-Rong Pan, Chang-Tai Xu, Jun Yun. Epidemiology and gene markers of ulcerative colitis in the Chinese. World Journal of Gastroenterology 2009; 15(7): 788-803 doi: 10.3748/wjg.15.788
|
| 37 |
Aidan Eric Juhl, Morten Westfall, Betina Hebbelstrup Jensen, Hengameh Chloé Mirsepasi-Lauridsen. Gut Microbiota in IBD: The Beneficial and Adverse Effects of Diet and Medication. Nutrients 2025; 18(1) doi: 10.3390/nu18010009
|
| 38 |
Arwa Kamoun, Dorra Bouzid, Nadia Mahfoudh, Ali Amouri, Lilia Gaddour, Faiza Hakim, Nabil Tahri, Hatem Masmoudi, Hafedh Makni. Association Study of MICA-TM Polymorphism with Inflammatory Bowel Disease in the South Tunisian Population. Genetic Testing and Molecular Biomarkers 2013; 17(8) doi: 10.1089/gtmb.2012.0423
|
| 39 |
Yang Cheng, Yun Zhu, Xiuping Huang, Wei Zhang, Zelong Han, Side Liu, David L Boone. Association between TLR2 and TLR4 Gene Polymorphisms and the Susceptibility to Inflammatory Bowel Disease: A Meta-Analysis. PLOS ONE 2015; 10(5) doi: 10.1371/journal.pone.0126803
|
| 40 |
Mauricio J. Farfan, Lidia Cantero, Alejandra Vergara, Roberto Vidal, Alfredo G. Torres. The long polar fimbriae of STEC O157:H7 induce expression of pro-inflammatory markers by intestinal epithelial cells. Veterinary Immunology and Immunopathology 2013; 152(1-2) doi: 10.1016/j.vetimm.2012.09.017
|
| 41 |
Jesús K. Yamamoto-Furusho, Gabriela Fonseca-Camarillo. Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(11) doi: 10.1097/MIB.0000000000000500
|
| 42 |
Jun Chen, Jianan Ren, Guosheng Gu, Gefei Wang, Xiuwen Wu, Dongsheng Yan, Song Liu, Jieshou Li. Crohn's disease and polymorphism of heat shock protein gene HSP70‐2 in the Chinese population. Journal of Gastroenterology and Hepatology 2013; 28(5) doi: 10.1111/jgh.12163
|
| 43 |
Gopabandhu Jena, Priyanka Pushkarbhai Trivedi, Balanarsimha Sandala. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radical Research 2012; 46(11) doi: 10.3109/10715762.2012.717692
|
| 44 |
Anastasia P. Nesterova, Eugene A. Klimov, Maria Zharkova, Sergey Sozin, Vladimir Sobolev, Natalia V. Ivanikova, Maria Shkrob, Anton Yuryev. Disease Pathways. 2020; doi: 10.1016/B978-0-12-817086-1.00010-5
|
| 45 |
Gregory R. Emkey, Sol Epstein. Secondary osteoporosis: Pathophysiology & diagnosis. Best Practice & Research Clinical Endocrinology & Metabolism 2014; 28(6) doi: 10.1016/j.beem.2014.07.002
|